Document is current
Any future updates will be listed below
-
Authors
Tischler, Luisa
Pfeuffer, Nils
Jordan, Yvonne
Heimbuch, Sarah
Krause, Heiko
Beyer, Angelika
Zach, Maria
Bertsche, Astrid
Gesser, Udo
Krohn, Markus
Fleßa, Steffen
Hoffmann, Wolfgang
van den Berg, Neeltje
-
Funding
Funding for this research was provided by:
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 29 April 2025
Accepted: 20 June 2025
First Online: 17 September 2025
Declarations
:
: This study was approved by the University Medicine Greifswald Research Ethics Committee (approval no. BB 132/20) on August 13, 2020, by the University Medicine Rostock Research Ethics Committee (approval no. A 2021–0086) on April 21, 2021, and by the Research Ethics Committee of the State Chamber of Physicians of Brandenburg (approval no. AS 88(bB)/2020) on November 04, 2020. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki.All participants provided written informed consent prior to participating.
: Not applicable.
: AB reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Jazz Pharmaceuticals GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. All other authors declare that they have no competing interests.All other authors declare that they have no competing interests.
